Volume 64, Issue 1, Pages (July 2003)

Slides:



Advertisements
Similar presentations
Volume 68, Pages S24-S28 (July 2005)
Advertisements

Volume 59, Issue 3, Pages (March 2001)
Volume 60, Issue 3, Pages (September 2001)
Volume 60, Issue 6, Pages (December 2001)
Volume 90, Issue 1, Pages (July 2016)
Volume 67, Pages S1-S7 (June 2005)
Volume 86, Issue 6, Pages (December 2014)
Volume 64, Issue 3, Pages (September 2003)
Volume 88, Issue 6, Pages (December 2015)
Furosemide stimulates macula densa cyclooxygenase-2 expression in rats
Volume 90, Issue 1, Pages (July 2016)
A trial of thyroxine in acute renal failure
Volume 67, Issue 2, Pages (February 2005)
FGF23–parathyroid interaction: implications in chronic kidney disease
The Case ∣ Generalized petechiae and acute renal failure
Volume 92, Issue 1, Pages (July 2017)
M. Fukagawa, S. Nakanishi, J.J. Kazama  Kidney International 
Differential effects of 19-nor-1,25-(OH)2D2 and 1α-hydroxyvitamin D2 on calcium and phosphorus in normal and uremic rats  Eduardo Slatopolsky, Mario Cozzolino,
Volume 60, Issue 6, Pages (December 2001)
Volume 60, Issue 4, Pages (October 2001)
Volume 64, Issue 2, Pages (August 2003)
Karl A. Nath, Anthony J. Croatt, Jill J. Haggard, Joseph P. Grande 
Volume 60, Issue 3, Pages (September 2001)
Volume 55, Issue 1, Pages (January 1999)
Volume 64, Issue 5, Pages (November 2003)
Tally Naveh-Many, Justin Silver  Kidney International 
Circulating PTH molecular forms: What we know and what we don't
Proinflammatory effects of iron sucrose in chronic kidney disease
Volume 79, Pages S20-S23 (April 2011)
Influence of parathyroid mass on the regulation of PTH secretion
Use of vitamin D in chronic kidney disease patients
Plasma FGF23 levels increase rapidly after acute kidney injury
Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease  S. Bianchi, R. Bigazzi, V.M. Campese 
Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.
Ewa Lewin, Yolanda Almaden, Mariano Rodriguez, Klaus Olgaard 
Volume 80, Issue 5, Pages (September 2011)
COX-2 inhibition attenuates endotoxin-induced downregulation of organic anion transporters in the rat renal cortex  Klaus Höcherl, Christoph Schmidt,
Volume 55, Issue 1, Pages (January 1999)
Relationship between methylmalonic acid and cobalamin in uremia
Volume 68, Pages S24-S28 (July 2005)
Cyclosporine A attenuates the natriuretic action of loop diuretics by inhibition of renal COX-2 expression  Klaus Höcherl, Frieder Kees, Bernhard K. Krämer,
Volume 87, Issue 3, Pages (March 2015)
Volume 59, Issue 3, Pages (March 2001)
Increased workload fully activates the blunted IRS-1/PI3-kinase/Akt signaling pathway in atrophied uremic muscle  Y. Chen, S. Sood, J. Biada, R. Roth,
Pathogenesis of refractory secondary hyperparathyroidism
Volume 79, Issue 7, Pages (April 2011)
Volume 75, Issue 9, Pages (May 2009)
Volume 54, Issue 1, Pages (July 1998)
Steven J. Harper, Charles R.V. Tomson, David O. Bates 
Phosphate and the parathyroid
Pablo A. Ureña Torres, Marc De Broe  Kidney International 
Volume 80, Issue 10, Pages (November 2011)
Volume 62, Issue 3, Pages (September 2002)
Increased parathyroid expression of klotho in uremic rats
Volume 70, Issue 3, Pages (August 2006)
A trial of thyroxine in acute renal failure
Volume 62, Issue 4, Pages (October 2002)
Volume 65, Issue 3, Pages (March 2004)
Recent developments in the management of secondary hyperparathyroidism
Cardiac resistance to growth hormone in uremia
Chronic metabolic acidosis in azotemic rats on a high-phosphate diet halts the progression of renal disease  Aquiles Jara, Arnold J. Felsenfeld, Jordi.
Cheryl P. Sanchez, Yu-Zhu He, Ellen Leiferman, Norman J. Wilsman 
Tumor necrosis factor-α in cisplatin nephrotoxicity: A homebred foe?
Control of uremic bone disease: Role of vitamin D analogs
Volume 74, Issue 10, Pages (November 2008)
Volume 61, Issue 4, Pages (April 2002)
Volume 54, Issue 6, Pages (January 1998)
Volume 55, Issue 5, Pages (May 1999)
A novel mechanism for skeletal resistance in uremia
Volume 86, Issue 2, Pages (August 2014)
Presentation transcript:

Volume 64, Issue 1, Pages 63-70 (July 2003) Autoregulation in the parathyroid glands by PTH/PTHrP receptor ligands in normal and uremic rats  Ewa Lewin, Bartolome Garfia, Yolanda Almaden, Mariano Rodriguez, Klaus Olgaard  Kidney International  Volume 64, Issue 1, Pages 63-70 (July 2003) DOI: 10.1046/j.1523-1755.2003.00056.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Effect of increasing doses of N-terminal parathyroid hormone-related protein (PTHrP) 1-40 on the secretory response of PTH to an acute induction of hypocalcemiain normal rats. Hypocalcemia (A) was induced by an ethyleneglycol tetraacetic acid (EGTA) infusion. The rate of reduction of plasma Ca++ was similar in all groups of rats (B). A bolus of PTHrP 1-40 or vehicle was injected at time 0. PTHrP 1-40 enhanced significantly (P < 0.01) in a dose-related manner the low Ca++-stimulated PTH secretion. N = 6 in each group, mean ± SEM. Kidney International 2003 64, 63-70DOI: (10.1046/j.1523-1755.2003.00056.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 Representative electropherograms of parathyroid hormone/parathyroid hormone-related protein (PTH/PTHrP) receptor mRNAs in three different samples of normal rat kidney cortex and parathyroid glands. Kidney International 2003 64, 63-70DOI: (10.1046/j.1523-1755.2003.00056.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 3 The relative secretory capacity of the parathyroid glands in normal rats, uremic rats kept on normal diet [chronic renal failure (CRF)], and uremic rats kept on high phosphorus diet [CRF high phosphorus (P)]. The relative secretory capacity is defined as the relative increase in parathyroid hormone (PTH) secretion from baseline in response to an acute induction of hypocalcemia, and expressed in percent of basal PTH levels. The relative secretory capacity is significantly decreased in uremia (P < 0.05) and practically 0 in uremic rats kept on high phosphorus diet. N = 6 to 9, mean ± SEM. Kidney International 2003 64, 63-70DOI: (10.1046/j.1523-1755.2003.00056.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 4 The effect of parathyroid hormone-related protein (PTHrP) 1-40 on the secretory response of parathyroid hormone (PTH) to an acute induction of hypocalcemia in uremic rats kept on a standard diet (- – -) and in normal rats (______) (A). Hypocalcemia was induced by an ethyleneglycol tetraacetic acid (EGTA) infusion. The rate of reduction of plasma Ca++ was similar in all groups of rats (B). A bolus of PTHrP 1-40 or vehicle was injected at time 0. PTHrP significantly enhanced the low Ca++-stimulated PTH secretion in both group of rats (P < 0.01). N = 6 in each group, mean ± SEM. CRF is chronic renal failure. Kidney International 2003 64, 63-70DOI: (10.1046/j.1523-1755.2003.00056.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 5 The Ca++/parathyroid hormone (PTH) relationship during ethyleneglycol tetraacetic acid (EGTA)-induced hypocalcemia in uremic rats kept on a high phosphorus diet and receiving a bolus injection of parathyroid hormone-related protein (PTHrP) 1-40 or vehicle. The arrow depicts the direction of change of plasma Ca++. In the vehicle-treated rats, induction of severe hypocalcemia did not further enhance PTH levels. Administration of PTHrP 1-40 did, however, enhance the PTH levels significantly (P < 0.001). N = 9 in each group, mean ± SEM. Kidney International 2003 64, 63-70DOI: (10.1046/j.1523-1755.2003.00056.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 6 The relative secretory capacity of the parathyroids in uremic rats kept on a high phosphorus diet after administration of parathyroid hormone-related protein (PTHrP) 1-40. The relative secretory capacity is defined as the relative increase in parathyroid hormone (PTH) secretion from baseline in response to an acute induction of hypocalcemia, and expressed in percent of basal PTH levels. The relative secretory capacity is significantly increased by PTHrP (P < 0.01). N = 9 in each group, mean ± SEM. EGTA is ethyleneglycol tetraacetic acid. Kidney International 2003 64, 63-70DOI: (10.1046/j.1523-1755.2003.00056.x) Copyright © 2003 International Society of Nephrology Terms and Conditions